Blood eosinophilic relative count is prognostic for breast cancer and associated with the presence of tumor at diagnosis and at time of relapse.
Concetta Elisa OnestiClaire JosseDelphine BouletJérôme ThiryBarbara BeaumeckerVincent BoursGuy JerusalemPublished in: Oncoimmunology (2020)
REC could be a new promising, affordable and accessible predictive and prognostic biomarker in all breast cancer subtypes.
Keyphrases